5 Min
In Sponsored education
Bookmark
Managing moderate to severe hay fever
Dymista® Control nasal spray is the first Pharmacy-only (P) nasal spray in the UK that contains a combination of an antihistamine and a corticosteroid. It is indicated to relieve symptoms of moderate to severe seasonal allergic rhinitis (AR), or hay fever, in adults if monotherapy with either intranasal antihistamine or corticosteroid is not considered sufficient.1
Learning objectives
Understand how Dymista® Control differs from other treatment options for hay fever available from the pharmacy
Recognise when Dymista® Control may be suitable to help relieve symptoms of hay fever
Provide advice on the appropriate use of Dymista® Control
This training module is not intended to replace the Dymista® Control nasal spray Risk Minimisation Material (RMM). You can access the Pharmacy Essential Guide (RMM) through the link provided at the end of this module.
For key points about Dymista® Control, please refer to the summary card.
Content developed by Viatris, working with CIG Healthcare Partnership.
© 2025 CIG Healthcare Partnership
UK-DTC-2025-00003 March 2025